JFS Wealth Advisors’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-61
Closed -$6.2K 1914
2025
Q4
$6.2K Sell
61
-247
-80% -$19.8K ﹤0.01% 1152
2025
Q3
$16.9K Buy
308
+273
+780% +$13.6K ﹤0.01% 733
2025
Q2
$1.86K Sell
35
-15
-30% -$762 ﹤0.01% 1411
2025
Q1
$2.17K Sell
50
-1
-2% -$51 ﹤0.01% 1440
2024
Q4
$2.87K Buy
51
+1
+2% +$62 ﹤0.01% 1339
2024
Q3
$3.41K Hold
50
﹤0.01% 1259
2024
Q2
$2.11K Hold
50
﹤0.01% 1411
2024
Q1
$3.45K Sell
50
-13
-21% -$822 ﹤0.01% 1238
2023
Q4
$4.66K Sell
63
-2
-3% -$131 ﹤0.01% 1086
2023
Q3
$4.43K Hold
65
﹤0.01% 1038
2023
Q2
$6.1K Buy
65
+4
+7% +$312 ﹤0.01% 914
2023
Q1
$4.14K Buy
61
+11
+22% +$707 ﹤0.01% 1072
2022
Q4
$2.48K Buy
50
+5
+11% +$204 ﹤0.01% 1289
2022
Q3
$1K Buy
45
+43
+2,150% +$1.77K ﹤0.01% 1542
2022
Q2
$0 Sell
2
-28
-93% -$1.5K ﹤0.01% 1803
2022
Q1
$2K Buy
30
+19
+173% +$1.39K ﹤0.01% 1401
2021
Q4
$1K Buy
+11
New +$971 ﹤0.01% 1340

Other funds holding EXAS

JFS Wealth Advisors's EXAS Position: Q1 2026 in Review

JFS Wealth Advisors sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 61 shares — an estimated $6.2K sold.

JFS Wealth Advisors first reported a position in EXAS in Q4 2021 and held it in 17 quarters. The position peaked at $16.9K in Q3 2025. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

  • JFS Wealth Advisors reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
  • JFS Wealth Advisors sold 61 Exact Sciences shares in Q1 2026, an estimated $6.2K.
  • JFS Wealth Advisors first reported a position in Exact Sciences in Q4 2021 and held it in 17 quarters.
  • JFS Wealth Advisors's Exact Sciences position peaked at $16.9K in Q3 2025.
  • 7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on JFS Wealth Advisors's 13F filing for Q1 2026, filed 21 Apr 2026.